Back
Anavex Life Sciences 10K Form
Sell
35
AVXL
Anavex Life Sciences
Last Price:
3.68
Seasonality Move:
11.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-08-08 | 10Q | AVXL/Anavex Life Sciences Quarterly |
| 2023-05-09 | 10Q | AVXL/Anavex Life Sciences Quarterly |
| 2023-02-07 | 10Q | AVXL/Anavex Life Sciences Quarterly |
| 2022-08-09 | 10Q | AVXL/Anavex Life Sciences Quarterly |
| 2022-05-10 | 10Q | AVXL/Anavex Life Sciences Quarterly |
| 2022-02-09 | 10Q | AVXL/Anavex Life Sciences Quarterly |
Receive AVXL News And Ratings
See the #1 stock for the next 7 days that we like better than AVXL
AVXL Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-7.32M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.65 |
| Price / Book: | 2.21 |
Profitability
| EPS (TTM): | -0.55000 |
|---|---|
| Net Income (TTM): | $-43.16M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Anavex Life Sciences Earnings Forecast
Key Anavex Life Sciences Financial Ratios
- The Interest Expense is -2.03% of Operating Income.
- Per Share Earnings over the last 20 years have been positive in 8 years.
Anavex Life Sciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AVXL |
| CUSIP: | 032797 |
| Website: | anavex.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AVXL Technical Analysis vs Fundamental Analysis
Sell
35
Anavex Life Sciences (AVXL)
is a Sell
Is Anavex Life Sciences a Buy or a Sell?
-
Anavex Life Sciences stock is rated a Sell
The current Anavex Life Sciences [AVXL] share price is $3.65. The Score for AVXL is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.